Clinical Trials · NCT02442791
GLP-1 Analogs for Neuroprotection After Cardiac Arrest
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Jesper Kjaergaard
- Enrollment
- 120
- Start date
- Jun 2014
- Locations
- 1 site, Denmark
- Primary endpoint
- Feasibility: Over 90% initiation of study drug infusion